Related Experiment Video
Updated: Aug 6, 2026

Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
Published on: September 17, 2012
Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover
1Laboratory of Biological Chemistry, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA.
Abstract:
Prostaglandin A(2) (PGA(2)), an experimental chemotherapeutic agent, causes growth arrest associated with decreased cyclin D1 expression in several cancer cell lines. Here, using human non-small-cell lung carcinoma H1299 cells, we investigated the mechanisms whereby PGA(2) down-regulates cyclin D1 expression. Transcription rates of the cyclin D1 gene, studied using a cyclin D1 promoter-luciferase construct and nuclear run-on assays, were not affected by PGA(2) treatment. Instead, the cyclin D1 mRNA was rendered unstable after exposure to PGA(2). Since the stability of labile mRNA is modulated through binding of proteins to specific mRNA sequences, we sought to identify protein(s) recognizing the cyclin D1 mRNA. In electrophoretic mobility-shift assays using radiolabeled RNA probes derived from different regions of cyclin D1 mRNA, we observed that (i) lysates prepared from PGA(2)-treated cells exhibited enhanced protein-cyclin D1 RNA complex formation; (ii) the kinetics of complex formation correlated closely with that of cyclin D1 mRNA loss; and (iii) binding occurred within a 390-base cyclin D1 3' untranslated region (UTR) (K12). This binding activity could be cross-linked, revealing proteins ranging from 30 to 47 kDa. The RNA-binding protein AUF1, previously associated with the degradation of target mRNAs, bound cyclin D1 mRNA, because anti-AUF1 antibodies were capable of supershifting or immunoprecipitating cyclin D1 mRNA-protein complexes. Finally, insertion of K12 in the 3'UTR of reporter genes markedly reduced the expression and half-life of the resulting chimeric mRNAs in transfected, PGA(2)-treated cells. Our data demonstrate that PGA(2) down-regulates cyclin D1 expression by decreasing cyclin D1 mRNA stability and implicates a 390-base element in the 3'UTR in this regulation.
Insights
Prostaglandin A(2) (PGA(2)) reduces cyclin D1 expression by destabilizing its mRNA in lung cancer cells. This involves AUF1 binding to a specific region in the 3' untranslated region of cyclin D1 mRNA.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Prostaglandin A(2) (PGA(2)) is an experimental chemotherapeutic agent known to reduce cyclin D1 expression and cause growth arrest in various cancer cell lines.
- The precise molecular mechanisms by which PGA(2) down-regulates cyclin D1 expression remain to be fully elucidated, particularly in non-small-cell lung carcinoma.
Purpose of the Study:
- To investigate the mechanisms underlying PGA(2)-induced down-regulation of cyclin D1 expression in human non-small-cell lung carcinoma H1299 cells.
- To identify the specific mRNA elements and protein factors involved in regulating cyclin D1 mRNA stability upon PGA(2) treatment.
Main Methods:
- Utilized a cyclin D1 promoter-luciferase construct and nuclear run-on assays to assess gene transcription rates.
- Employed electrophoretic mobility-shift assays (EMSA) with radiolabeled RNA probes to detect protein-RNA interactions.
- Performed RNA-binding protein cross-linking, antibody supershifting, and immunoprecipitation assays to identify and confirm protein binding.
- Assessed mRNA stability and expression of reporter genes containing specific cyclin D1 3' untranslated region (UTR) elements in transfected cells.
Main Results:
- PGA(2) treatment did not affect cyclin D1 gene transcription rates but significantly decreased cyclin D1 mRNA stability.
- Electrophoretic mobility-shift assays revealed enhanced protein binding to cyclin D1 mRNA in PGA(2)-treated cells, correlating with mRNA loss.
- Binding activity was localized to a 390-base element (K12) within the cyclin D1 3' UTR.
- The RNA-binding protein AUF1 was identified as a key factor binding to cyclin D1 mRNA, confirmed by antibody-based assays.
- Insertion of the K12 element into reporter gene 3' UTRs markedly reduced expression and half-life in PGA(2)-treated cells.
Conclusions:
- PGA(2) down-regulates cyclin D1 expression primarily by decreasing cyclin D1 mRNA stability, not by affecting transcription.
- A specific 390-base element in the 3' UTR of cyclin D1 mRNA is crucial for mediating this PGA(2)-induced destabilization.
- The RNA-binding protein AUF1 plays a significant role in the PGA(2)-mediated decay of cyclin D1 mRNA.
Related Concept Videos
Positive Regulator Molecules
Negative Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

